Here's an angle that occurred to me when I looked into Raymond Schinazi at Emory to ask what further research they were were doing on XMRV (they are doing trials on animals before humans). He has been a major player in developing in anti-AIDS drugs. Indeed, his bio reads "Dr. Schinazi is the founder of several biotechnology companies focusing on antiviral drug discovery and development, including Pharmasset Inc., Triangle Pharmaceuticals (acquired by Gilead in 2003), Idenix Pharmaceuticals (51% acquired by Novartis in 2003), and RFS Pharma LLC (formed in Sept 2004). He has published over 420 peer-reviewed papers and 7 books, and holds more than 70 US patents. He is best known for his innovative and pioneering work on d4T (stavudine), 3TC (lamivudine), FTC (emtriva), D-D4FC (reverset), RCV (racivir), and DAPD (amdoxovir), drugs that are now approved by the FDA, or are at various stages of clinical development. His inventions now sell more than US$2.0 billion per year and more than 80% of the HIV infected individuals take at least one of the drugs he invented."
It has occurred to me that the makers of anti-HIV drugs have a very real interest in proving that a link exists between XMRV and CFS because if they can then prove that a clear XMRV/CFS connection, they have increased their anti-HIV drug market by 10 or 11 times, right? Maybe this is where research money comes from? Drug companies? Or is this too cynical? Or tainted?
I have no experience with any of this - just random thoughts of a foggy-brained bystander.:tongue: So if this is exceptionally dumb, just ignore!
